Targeting desmoplasia in pancreatic cancer as an essential first step to effective therapy
Targeting desmoplasia in pancreatic cancer as an essential first step to effective therapy |
|
https://doi.org/10.18632/oncotarget.27745
Nancy D. Ebelt,
Vic Zamloot,
and Edwin R. Manuel
|
| 3486-3488 |
A comprehensive analysis of clinical trials in pancreatic cancer: what is coming down the pike?
A comprehensive analysis of clinical trials in pancreatic cancer: what is coming down the pike? |
|
https://doi.org/10.18632/oncotarget.27727
Erryk S. Katayama,
Jonathan J. Hue,
David L. Bajor,
Lee M. Ocuin,
John B. Ammori,
Jeffrey M. Hardacre,
and Jordan M. Winter
|
| 3489-3501 |
Pharmacological targeting of mitochondrial function and reactive oxygen species production prevents colon 26 cancer-induced cardiorespiratory muscle weakness
Pharmacological targeting of mitochondrial function and reactive oxygen species production prevents colon 26 cancer-induced cardiorespiratory muscle weakness |
|
https://doi.org/10.18632/oncotarget.27748
Ashley J. Smuder,
Brandon M. Roberts,
Michael P. Wiggs,
Oh Sung Kwon,
Jeung-Ki Yoo,
Demetra D. Christou,
David D. Fuller,
Hazel H. Szeto,
and Andrew R. Judge
|
| 3502-3514 |
Altered lung tissue lipidomic profile in caspase-4 positive non-small cell lung cancer (NSCLC) patients
Altered lung tissue lipidomic profile in caspase-4 positive non-small cell lung cancer (NSCLC) patients |
|
https://doi.org/10.18632/oncotarget.27724
Michela Terlizzi,
Antonio Molino,
Chiara Colarusso,
Pasquale Somma,
Ilaria De Rosa,
Jacopo Troisi,
Giovanni Scala,
Rosario Salvi,
Aldo Pinto,
and Rosalinda Sorrentino
|
| 3515-3525 |
A low psoas muscle volume is associated with a poor prognosis in penile cancer
A low psoas muscle volume is associated with a poor prognosis in penile cancer |
|
https://doi.org/10.18632/oncotarget.27719
Daiji Takkamoto,
Takashi Kawahara,
Takashi Tokita,
Jun Kasuga,
Yasushi Yumura,
and Hiroji Uemura
|
| 3526-3530 |
Advances in epidermal growth factor receptor specific immunotherapy: lessons to be learned from armed antibodies
Advances in epidermal growth factor receptor specific immunotherapy: lessons to be learned from armed antibodies |
|
https://doi.org/10.18632/oncotarget.27730
Fleury Augustin Nsole Biteghe,
Neelakshi Mungra,
Nyangone Ekome Toung Chalomie,
Jean De La Croix Ndong,
Jean Engohang-Ndong,
Guillaume Vignaux,
Eden Padayachee,
Krupa Naran,
and Stefan Barth
|
| 3531-3557 |
Correction: Melatonin attenuated the brain damage and cognitive impairment partially through MT2 melatonin receptor in mice with chronic cerebral hypoperfusion
Correction: Melatonin attenuated the brain damage and cognitive impairment partially through MT2 melatonin receptor in mice with chronic cerebral hypoperfusion |
|
https://doi.org/10.18632/oncotarget.27754
Tzu-Hsien Tsai,
Cheng-Jei Lin,
Sarah Chua,
Sheng-Ying Chung,
Cheng-Hsu Yang,
Meng-Shen Tong,
and Chi-Ling Hang
|
| 3558-3558 |
